The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Setting a precedent: Development of a core outcome set for locoregional treatment outcome reporting in neoadjuvant breast cancer trials.
 
Stuart McIntosh
Honoraria - AstraZeneca (Inst); MSD (Inst); Roche (Inst)
Consulting or Advisory Role - Lilly (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Speakers' Bureau - AstraZeneca (Inst); Exact Sciences (Inst); MSD (Inst); Roche (Inst); Veracyte (Inst)
Travel, Accommodations, Expenses - Lilly; Novartis; Roche
 
Peter Dubsky
Honoraria - AstraZeneca; OncoViews
Consulting or Advisory Role - Roche
Research Funding - Cepheid (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Kerry Avery
No Relationships to Disclose
 
Jana de Boniface
No Relationships to Disclose
 
David Dodwell
No Relationships to Disclose
 
Sandra Finestone
No Relationships to Disclose
 
Hiroji Iwata
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Hakko Kirin; Lilly Japan; MSD; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly Japan; MSD; Novartis; Pfizer; Sanofi
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); MSD (Inst); Nihonkayaku (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Michael Jiang
No Relationships to Disclose
 
Han-Byoel Lee
Leadership - DCGen
Stock and Other Ownership Interests - DCGen
Honoraria - Alvogen Korea; Boryung; Roche; Takeda
Consulting or Advisory Role - Boryung; Lilly; Need, Inc. (Inst); Novartis
Research Funding - Devicor Medical Products
Patents, Royalties, Other Intellectual Property - Patent for an NGS-based breast cancer multigene prognostic panel
Travel, Accommodations, Expenses - DCGen
 
Mairead MacKenzie
No Relationships to Disclose
 
Anne Meyn
No Relationships to Disclose
 
Philip Poortmans
No Relationships to Disclose
 
Fiorita Poulakaki
Travel, Accommodations, Expenses - GENECOR
 
Orit Person
No Relationships to Disclose
 
Andrew Spillane
No Relationships to Disclose
 
Alastair Thompson
Employment - Lilly (I)
Stock and Other Ownership Interests - Lilly (I)
 
Gustavo Werutsky
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; MSD; Novartis; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Libbs (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche/Genentech (Inst); Takeda (Inst)
 
Jean Wright
Employment - Johns Hopkins Hospital; University of North Carolina at Chapel Hill
Honoraria - American Society for Radiation Oncology; Physicans' Education Resource
Research Funding - Oncospace; Prostate Cancer Foundation-Pfizer Health Equity Challenge (Inst); Prostate Cancer Foundation-Pfizer Health Equity Challenge (Inst)
Patents, Royalties, Other Intellectual Property - Spouse receives royalties from Up To Date (I)
Expert Testimony - Wicker Smith
(OPTIONAL) Uncompensated Relationships - American Society for Radiation Oncology; International Journal of Radiation Oncology Biology Physics
 
Nicholas Zdenkowski
Honoraria - AstraZeneca; Eisai; Gilead Sciences; Lilly; Menarini; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; MSD; Novartis; Roche
Research Funding - Lilly (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Lilly; Novartis; Pfizer; Roche
 
Shelley Potter
No Relationships to Disclose